Vergleich von Diagnosedaten nach der Einführung des Mukoviszidosescreenings bei Neugeborenen in Deutschland

BACKGROUND: In Germany, newborn screening (NGS) for cystic fibrosis (CF) was introduced on 1 September 2016. There is no legally required follow-up of abnormal screening findings, so the exact number of final diagnoses is not known. Two data sources can support the evaluation of the cystic fibrosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Nährlich, Lutz, Brockow, Inken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Leitthema
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622368/
https://www.ncbi.nlm.nih.gov/pubmed/37831094
http://dx.doi.org/10.1007/s00103-023-03778-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622368/
https://www.ncbi.nlm.nih.gov/pubmed/37831094
http://dx.doi.org/10.1007/s00103-023-03778-1

Ejemplares similares